Cdc7-dbf4 and the human S checkpoint response to UVC

被引:52
作者
Heffernan, Timothy P.
Unsal-Kacmaz, Keziban
Heinloth, Alexandra N.
Simpson, Dennis A.
Paules, Richard S.
Sancar, Aziz
Cordeiro-Stone, Marila
Kaufmann, William K. [1 ]
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Ctr Environm Hlth & Susceptibil, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[5] NIEHS, Growth Control & Canc Grp, NIH, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1074/jbc.M611292200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The S checkpoint response to ultraviolet radiation (UVC) that inhibits replicon initiation is dependent on the ATR and Chk1 kinases. Downstream effectors of this response, however, are not well characterized. Data reported here eliminated Cdc25A degradation and inhibition of Cdk2-cyclin E as intrinsic components of the UVC-induced pathway of inhibition of replicon initiation in human cells. A sublethal dose of UVC (1 j/m(2)), which selectively inhibits replicon initiation by 50%, failed to reduce the amount of Cdc25A protein or decrease Cdk2-cyclin E kinase activity. Cdc25A degradation was observed after irradiation with cytotoxic fluences of UVC, suggesting that severe inhibition of DNA chain elongation and activation of the replication checkpoint might be responsible for the UVC-induced degradation of Cdc25A. Another proposed effector of the S checkpoint is the Cdc7-Dbf4 complex. Dbf4 interacted weakly with Chk1 in vivo but was recognized as a substrate for Chk1-dependent phosphorylation in vitro. FLAG-Dbf4 formed complexes with endogenous Cdc7, and this interaction was stable in UVC-irradiated HeLa cells. Overexpression of FLAG- or Myc-tagged Dbf4 abrogated the S checkpoint response to UVC but not ionizing radiation. These findings implicate a Dbf4-dependent kinase as a possible target of the ATR- and Chk1-dependent S checkpoint response to UVC.
引用
收藏
页码:9458 / 9468
页数:11
相关论文
共 81 条
[1]   Cell cycle checkpoint signaling through the ATM and ATR kinases [J].
Abraham, RT .
GENES & DEVELOPMENT, 2001, 15 (17) :2177-2196
[2]   Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway [J].
Agner, J ;
Falck, J ;
Lukas, J ;
Bartek, J .
EXPERIMENTAL CELL RESEARCH, 2005, 302 (02) :162-169
[3]   Differential assembly of Cdc45p and DNA polymerases at early and late origins of DNA replication [J].
Aparicio, OM ;
Stout, AM ;
Bell, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :9130-9135
[4]   DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation [J].
Bakkenist, CJ ;
Kastan, MB .
NATURE, 2003, 421 (6922) :499-506
[5]   ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses [J].
Bao, SD ;
Tibbetts, RS ;
Brumbaugh, KM ;
Fang, YN ;
Richardson, DA ;
Ali, A ;
Chen, SM ;
Abraham, RT ;
Wang, XF .
NATURE, 2001, 411 (6840) :969-974
[6]   Checking on DNA damage in S phase [J].
Bartek, J ;
Lukas, C ;
Lukas, J .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (10) :792-804
[7]   Cell cycle regulation of Dfp1, an activator of the Hsk1 protein kinase [J].
Brown, GW ;
Kelly, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8443-8448
[8]   Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase [J].
Bulavin, DV ;
Higashimoto, Y ;
Popoff, IJ ;
Gaarde, WA ;
Basrur, V ;
Potapova, O ;
Appella, E ;
Fornace, AJ .
NATURE, 2001, 411 (6833) :102-107
[9]   Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage [J].
Busino, L ;
Donzelli, M ;
Chiesa, M ;
Guardavaccaro, D ;
Ganoth, D ;
Dorrello, NV ;
Hershko, A ;
Pagano, M ;
Draetta, GF .
NATURE, 2003, 426 (6962) :87-91
[10]   Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway [J].
Chaturvedi, P ;
Eng, WK ;
Zhu, Y ;
Mattern, MR ;
Mishra, R ;
Hurle, MR ;
Zhang, XL ;
Annan, RS ;
Lu, Q ;
Faucette, LF ;
Scott, GF ;
Li, XT ;
Carr, SA ;
Johnson, RK ;
Winkler, JD ;
Zhou, BBS .
ONCOGENE, 1999, 18 (28) :4047-4054